Company: TOXR
Filing Date: 2025-12-10
Form Type: 424B3
Source: 0001213900-25-120172
Chunk: 242

Company: 21Shares XRP ETF
Filing Date: 2025-12-10
Form: 424B3
Chunk 242
---
3</div>

21Shares XRP ETF

STATEMENTs oF
ASSETS AND LIABILITIES

(Expressed in United States Dollars)

| Assets                                                                             |     | August 31, 
 2025       |             |     | December 31, 
 2024         |             |   |
|:-----------------------------------------------------------------------------------|:----|:-----------|------------:|:----|:-------------|------------:|:--|
| Investment in XRP, at fair value (cost $217,299,657 and $220,676,000,              
 respectively)                                                                      |     | $          | 277,982,779 |     | $            | 209,510,000 |   |
| Total assets                                                                       |     |            | 277,982,779 |     |              | 209,510,000 |   |
| Liabilities                                                                        |     |            |             |     |              |             |   |
| Sponsor fee payable                                                                |     |            |     512,029 |     |              |     157,810 |   |
| Total liabilities                                                                  |     |            |     512,029 |     |              |     157,810 |   |
| Commitments and contingent liabilities (Note 8)                                    |     |            |             |     |              |             |   |
| Net assets                                                                         |     | $          | 277,470,750 |     | $            | 209,352,190 |   |
| Net assets consists of:                                                            |     |            |             |     |              |             |   |
| Paid-in capital                                                                    |     | $          | 220,676,000 |     | $            | 220,676,000 |   |
| Accumulated earnings (loss)                                                        |     |            |  56,794,750 |     |              | (11,323,810 | ) |
|                                                                                    |     | $          | 277,470,750 |     | $            | 209,352,190 |   |
| Shares issued and outstanding, no par value, unlimited amount of authorized shares |     |            |  10,000,000 |     |              |  10,000,000 |   |
| Net asset value per share                                                          |     | $          |       27.75 |     | $            |       20.94 |   |

<div align='center'>The accompanying notes are
an integral part